β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Tlhaloso e Khutšoanyane:

Lebitso: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9

Ponahalo: Phofo ea Crystalline e tšoeu kapa e sa Tšoeu

Tekanyetso: ≥99.0% (HPLC)

Bohareng ba Clofarabine (CAS: 123318-82-1) kalafo ea Bana ba nang le Acute Lymphoblastic Leukemia (ALL)

Inquiry: alvin@ruifuchem.com

Re romelle lengolo-tsoibila

Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Commercial Supply Clofarabine Intermediates Related:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale	β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Litlhaloso tse tšoanang	1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Nomoro ea CAS	6974-32-9
Nomoro ea KAtse	RF-PI222
Boemo ba Setoko	Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule	C28H24O9
Boima ba Molek'hule	504.49
Brand	Ruifu Chemical

Litlhaloso:

Ntho	Litlhaloso
Ponahalo	Phofo ea Crystalline e tšoeu kapa e sa Tšoeu
Mokhoa oa ho hlahloba / oa ho hlahloba	≥99.0% (HPLC)
Melting Point	126.0~133.0℃
Tahlehelo ka ho Omisa	≤0.50%
Masalla a ho Ignition	≤0.50%
Litšila ka Kakaretso	≤1.00%
Litšepe tse boima	≤20ppm
Tekanyetso ea Teko	Maemo a Khoebo
Tšebeliso	Pharmaceutical Intermediate ea Clofarabine CAS: 123318-82-1

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.

Melemo:

LBH:

Kopo:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) ke bohareng ba (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) ke "purine nucleoside anticancer drugs" e qalileng ka katleho ke Top10 biopharmaceutical company ea United States-Genzyme Corporation e nang le mabitso a khoebo "Clofarabine".Ka la 28 Tšitoe, 2004, US Food and Drug Administration (FDA) e sebelisitse lebelo le potlakileng bakeng sa tumello ea clofarabine bakeng sa ts'ebeliso ho bana ba nang le acute lymphocytic leukemia (ALL);e na le ts'ebetso e ntle haholo ea kalafo ea leukemia ka mamello e ntle mme ha e na litlamorao tse sa lebelloang.E ka tsamaisoa ka ho tsamaisoa ka methapo kapa ho tsamaisoa ka molomo.Setlhare sena ke sehlahisoa sa pele se lumelletsoeng ho inehela kalafong ea leukemia ea bana ka lilemo tse fetang leshome.